Cannabis testing labs routinely inflate THC potency numbers because the businesses they test are also their paying customers

Cannabis testing laboratories are private, for-profit companies whose revenue comes directly from the cultivators and manufacturers whose products they test. Labs that consistently report higher THC percentages and fewer failed batches attract more business, creating a structural conflict of interest. A 2023 University of Northern Colorado study found that nearly half of cannabis flower products in Colorado had inflated THC labels, and identical samples sent to different labs returned values varying by up to 38% -- more than double the state's allowable deviation. Why it matters: Consumers rely on THC labels to dose accurately, so inflated numbers cause people to consume more THC than intended, leading to adverse reactions like panic attacks, especially among new or medical users. Because adverse experiences erode consumer trust in the legal market, some consumers return to illicit sources where they at least know their dealer's product through personal experience, so the legal market loses customers. Labs that report honest results lose clients to inflated competitors, so honest labs face a race to the bottom and either inflate or go out of business. As honest labs exit, the entire testing infrastructure becomes unreliable, so regulators cannot confidently certify product safety for pesticides, heavy metals, and mold either. This means the core public health promise of legalization -- that legal cannabis is tested and safe -- is fundamentally undermined. The structural root cause is that no state has implemented a blind testing system where regulators, not the cannabis company, select and assign the testing lab. The operator picks and pays the lab directly, creating the same conflict of interest as if a restaurant chose and paid its own health inspector. Oklahoma suspended Greenleaf Labs in 2025 for unreliable safety results, but this was reactive enforcement, not a systemic fix.